可溶性环氧化物水解酶抑制剂对脑梗死的治疗研究
摘要
关键词
全文:
PDF参考
[1]Carver K A,D Lourim, Tryba A K,et al. Rhythmic expression of cytochrome P450 epoxygenases CYP4x1 and CYP2c11 in the rat brain and vasculature[J]. American Journal of Physiology Cell Physiology,2014,307(11):989-98.
[2]Nelson J W,Young J M ,Borkar R N ,et al. Role of soluble epoxide hydrolase in age-related vascular cognitive decline[J]. Prostaglandins Other Lipid Mediat,2014,113-115:30-37.
[3] Depaz I,Toselli F,Wilce P A , et al. Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain[J]. Drug Metabolism & Disposition,2015,43(3):353-357.
[4]Liu Y,Wan Y ,Fang Y,et al. Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia[J]. Journal of Molecular Neuroscience,2016,58(2):254-265.
[5]黄攀,易兴阳.新型可溶性环氧化物水解酶抑制剂TPPU对缺血性脑卒中的保护机制[J].中国老年学杂志,2021,41(24):5775-5777.
[6]Kristen, L, Zuloaga, et al. Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice[J]. Frontiers in Pharmacology, 2015,5:290
[7]Qu Y Y,Yuan M Y,Liu Y, et al. The Protective Effect of Epoxyeicosatrienoic Acids on Cerebral Ischemia/Reperfusion Injury is Associated with PI3K/Akt Pathway and ATP-Sensitive Potassium Channels[J]. Neurochemical Research,2015,40(1):874-874.
[8]Simpkins A N,Rudic R D,Schreihofer D A , et al. Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection[J]. American Journal of Pathology,2009,174(6):2086-2095.
[9]刘阳,郑小龙,喻志源等.CYP-EET信号通路对大鼠MCAO缺血再灌注后血管新生影响的研究[J].疑难病杂志,2020,19(5):500-504,515.
[10]Hui, Huang, Mohamed, et al. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke[J]. Prostaglandins & other lipid mediators,2016,122:45-53.
[11]Hung T H,Shyue S K,Wu C H, et al. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury[J]. Oncotarget,2017, 8(61):103236-103260.
[12]Tu R,Armstrong J,Lee K,et al. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia[J].Rep,2018,8(1):5279.
[13]Yi X, Fan D, Yi T, et al. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea Exerts Neuro-Protective Effects Against Ischemic Injury via Suppressing JNK/p38 MAPK-Mediated Mitochondrial Apoptosis Pathway[J].Stroke Cerebrovasc Dis. 2021;30(9):105957.
[14]Chien-Fu, Yeh, Tung-Yueh, et al. Inhibition of soluble epoxide hydrolase regulates m5nocyte/macrophage polarization and improves neurological outcome in a rat model of ischemic stroke [J]. Neuroreport, 2019,30(8):567-572.
[15]Wang Q,Liang Y ,Qiao Y, et al. Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy[J]. Am J Physiol Renal Physiol,2018,44315:915-926.
[16]Yeh C F ,Chuang T ,Hung Y W, et al. Soluble epoxide hydrolase inhibition enhances anti-inflammatory and antioxidative processes, modulates microglia polarization, and promotes recovery after ischemic stroke[J]. Neuropsychiatric Disease and Treatment,2019(15):2927-2941.
[17]Ruffell D, Mourkioti F, Gambardella A, et al. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair[J].Proc Natl Acad Sci U S A,2009,106(41):17475-17480.
[18]Yuan L ,Liu J ,Dong R, et al. 14,15-epoxyeicosatrienoic acid promotes production of BDNF from astrocytes and exerts neuroprotective effects during ischemic injury[J]. Neuropathology & Applied Neurobiology,2015:607-620.
[19]Hao T,Rockwell P.Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress[J]. Free Radical Biology & Medicine,2013,63:421-431.
[20]Zhang Y ,Hong G ,Lee K , et al. Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen‐glucose deprivation[J]. Journal of Neurochemistry, 2016,140(5):814-825.
[21]Lee KS, Liu JY, Wagner KM, et al. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy[J] [published correction appears in J Med Chem. 2018 May 10;61(9):4271].J Med Chem,2014;57(16):7016-7030.
[22]Hyo K,Sang K,Kang K.Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells[J]. International Journal of Molecular Sciences,2017,18(12):2683.
[23]Wang Q,Huo L,He J ,et al. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration[J]. Am J Physiol Heart Circ Physiol,2015, 309(11):1894-903.
[24]陈余雪,刘幸华,刘璐.可溶性环氧化物水解酶抑制剂TPPU促进低灌注脑白质损伤后髓鞘再生的相关机制[J].华中科技大学学报(医学版),2021,50(03):273-278.
[25]Chang L H ,Lin H C ,Huang S S , et al. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation[J]. Scientific Reports,2018,8(1):118.
[26]Hou H H ,Hammock B D ,Su K H ,et al. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase[J]. Cardiovascular Research,2012,93(1):120-9.
[27]Hou H H ,Liao Y J ,Hsiao S H , et al. Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase[J]. Scientific reports,2015,5:13524.
[28]Srivastava K, Bath PM, Bayraktutan U. Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke[J]. Cellular and molecular neurobiology. 2012,32(3):319-336.
[29]Wanjun, Liu, Tao, et al. CYP2J2 Overexpression Increases EETs and Protects Against HFD-Induced Atherosclerosis in ApoE-/- Mice[J]. Journal of cardiovascular pharmacology,2016,67(6):491-502.
[30]Zhang W,Otsuka T ,Sugo N , et al. Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia[J].Stroke,2008,39(7):2073-2078.
[31]Corenblum M J ,Wise V E,Georgi K , et al. Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat[J]. Hypertension,2008,51(2):567-573.
[32]Yi X, Wu L, Liao D, et al. Interactions among CYP2C8, EPHX2, and CYP4A11 variants and CYP plasma metabolite levels in ischemic stroke[J]. J Atheroscler Thromb,2016, 23(11):12861293.
[33]Yi X , Lin J , Wang C , et al. CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population[J]. Journal of Stroke & Cerebrovascular Diseases,2016:S1052305716304529.
[34]Yi X , Lin J , Li J , et al. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke[J]. Journal of Atherosclerosis & Thrombosis,2017, 24(12):1258-1266.
[35]Ma L, Jiang Y, Kong X, et al. Synergistic Effect of the MTHFR C677T and EPHX2 G860A Polymorphism on the Increased Risk of Ischemic Stroke in Chinese Type 2 Diabetic Patients[J]. J Diabetes Res.2017;2017:6216205.
[36]Can Demirdöğen B, Miçooğulları Y, Türkanoğlu Özçelik A, Adalı O. Missense Genetic Polymorphisms of Microsomal (EPHX1) and Soluble Epoxide Hydrolase (EPHX2) and Their Relation to the Risk of Large Artery Atherosclerotic Ischemic Stroke in a Turkish Population[J].Neuropsychiatr Dis Treat. 2021;16:3251-3265.
[37]Wang S B,Du G H . Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition[J]. Journal of Asian natural products research,2012, 14(11):1084-1092.
[38]Wang S B ,Pang X B ,Gao M , et al. Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids[J]. Chinese Journal of Natural Medicines,2014,11(3):207-213.
[39]Albers GW, Goldstein LB, Hess DC, et al. Stroke Treatment Academic Industry Roundtable(STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies[J].Stroke,2011,42:2645-2650.
[40]Sirish P, Li N, Liu JY, et al. Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis[J]. Proc Natl Acad Sci U S A,2013,110:5618-5623.
[41]Ulu A, Appt S, Morisseau C, et al. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys[J]. Br J Pharmacol, 2012,165:1401-1412.
[42]A A I O , A J H , A I W , et al. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern[J]. Prostaglandins & Other Lipid Mediators, 2015, 121(Pt A):131-137.
(0 摘要 Views, 1 PDF Downloads)
Refbacks
- 当前没有refback。